Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12782]

Nivolumab combined with ipilimumab safe as first-line therapy for lung cancer patients

Nivolumab combined with ipilimumab safe as first-line therapy for lung cancer patients

New KEYNOTE 021 data shows no association with tumour mutational burden

New KEYNOTE 021 data shows no association with tumour mutational burden

Mammography unlikely to benefit older women with chronic illnesses

Mammography unlikely to benefit older women with chronic illnesses

Trifluridine/tipiracil receives marketing authorisation in Europe for patients with previously treated metastatic gastric cancer

Trifluridine/tipiracil receives marketing authorisation in Europe for patients with previously treated metastatic...

Synthetic biologists extend functional life of cancer fighting circuitry in microbes

Synthetic biologists extend functional life of cancer fighting circuitry in microbes

Scientists confirm efficacy of a combination therapy for advanced liver cancer

Scientists confirm efficacy of a combination therapy for advanced liver cancer

New study reinforces clinical utility of combining TMB and PD-L1 as predictive biomarkers for immune checkpoint inhibitor therapy

New study reinforces clinical utility of combining TMB and PD-L1 as predictive biomarkers for immune checkpoint...

New mathematical model can improve radiation therapy of brain tumours

New mathematical model can improve radiation therapy of brain tumours

Study confirms protein as potential cause of most common type of pancreatic cancer

Study confirms protein as potential cause of most common type of pancreatic cancer

Low income cancer patients and those without insurance see fewer trial benefits

Low income cancer patients and those without insurance see fewer trial benefits

More from ecancer